CA2501587A1 — Solid preparation having phase containing insulin sensitizer and another active ingredient uniformly mixed
Assigned to Takeda Pharmaceutical Co Ltd · Expires 2004-04-15 · 22y expired
What this patent protects
It is intended to provide a solid preparation containing an insulin resistan ce improving drug and an active ingredient (other than the insulin resistance improving drug) which is useful as a remedy for diabetes, etc. and excellent in the uniformity in the contents of the insulin…
USPTO Abstract
It is intended to provide a solid preparation containing an insulin resistan ce improving drug and an active ingredient (other than the insulin resistance improving drug) which is useful as a remedy for diabetes, etc. and excellent in the uniformity in the contents of the insulin resistance improving drug a nd the active ingredient (other than the insulin resistance improving drug) and the preparation characteristics such as elution properties and preparation hardness.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.